193 related articles for article (PubMed ID: 26965566)
1. The activation and blockage of CRF type 2 receptors of the medial amygdala alter elevated T-maze inhibitory avoidance, an anxiety-related response.
Alves SW; Portela NC; Silva MS; Céspedes IC; Bittencourt JC; Viana MB
Behav Brain Res; 2016 May; 305():191-7. PubMed ID: 26965566
[TBL] [Abstract][Full Text] [Related]
2. CRF type 1 receptors of the medial amygdala modulate inhibitory avoidance responses in the elevated T-maze.
Vicentini JE; Céspedes IC; Nascimento JO; Bittencourt JC; Viana MB
Horm Behav; 2014 Mar; 65(3):195-202. PubMed ID: 24472740
[TBL] [Abstract][Full Text] [Related]
3. The blockage of ventromedial hypothalamus CRF type 2 receptors impairs escape responses in the elevated T-maze.
Silva MSCF; Souza TMO; Pereira BA; Ribeiro DA; Céspedes IC; Bittencourt JC; Viana MB
Behav Brain Res; 2017 Jun; 329():41-50. PubMed ID: 28435125
[TBL] [Abstract][Full Text] [Related]
4. Dorsomedial hypothalamus CRF type 1 receptors selectively modulate inhibitory avoidance responses in the elevated T-maze.
Silva MS; Pereira BA; Céspedes IC; Nascimento JO; Bittencourt JC; Viana MB
Behav Brain Res; 2014 Sep; 271():249-57. PubMed ID: 24937051
[TBL] [Abstract][Full Text] [Related]
5. Astressin, a corticotropin releasing factor antagonist, reverses the anxiogenic effects of urocortin when administered into the basolateral amygdala.
Sajdyk TJ; Gehlert DR
Brain Res; 2000 Sep; 877(2):226-34. PubMed ID: 10986336
[TBL] [Abstract][Full Text] [Related]
6. Effects of dorsal periaqueductal gray CRF1- and CRF2-receptor stimulation in animal models of panic.
Sergio Tde O; Spiacci A; Zangrossi H
Psychoneuroendocrinology; 2014 Nov; 49():321-30. PubMed ID: 25146701
[TBL] [Abstract][Full Text] [Related]
7. CRF receptor type 1 (but not type 2) located within the amygdala plays a role in the modulation of anxiety in mice exposed to the elevated plus maze.
Cipriano AC; Gomes KS; Nunes-de-Souza RL
Horm Behav; 2016 May; 81():59-67. PubMed ID: 27060334
[TBL] [Abstract][Full Text] [Related]
8. GABA/benzodiazepine receptors in the ventromedial hypothalamic nucleus regulate both anxiety and panic-related defensive responses in the elevated T-maze.
Bueno CH; Zangrossi H; Viana Mde B
Brain Res Bull; 2007 Sep; 74(1-3):134-41. PubMed ID: 17683799
[TBL] [Abstract][Full Text] [Related]
9. Dorsomedial hypothalamus serotonin 1A receptors mediate a panic-related response in the elevated T-maze.
Nascimento JO; Kikuchi LS; de Bortoli VC; Zangrossi H; Viana MB
Brain Res Bull; 2014 Oct; 109():39-45. PubMed ID: 25290207
[TBL] [Abstract][Full Text] [Related]
10. Modulation of learning and anxiety by corticotropin-releasing factor (CRF) and stress: differential roles of CRF receptors 1 and 2.
Radulovic J; Rühmann A; Liepold T; Spiess J
J Neurosci; 1999 Jun; 19(12):5016-25. PubMed ID: 10366634
[TBL] [Abstract][Full Text] [Related]
11. Use of the elevated T-maze to study anxiety in mice.
Carvalho-Netto EF; Nunes-de-Souza RL
Behav Brain Res; 2004 Jan; 148(1-2):119-32. PubMed ID: 14684253
[TBL] [Abstract][Full Text] [Related]
12. Delayed satiety-like actions and altered feeding microstructure by a selective type 2 corticotropin-releasing factor agonist in rats: intra-hypothalamic urocortin 3 administration reduces food intake by prolonging the post-meal interval.
Fekete EM; Inoue K; Zhao Y; Rivier JE; Vale WW; Szücs A; Koob GF; Zorrilla EP
Neuropsychopharmacology; 2007 May; 32(5):1052-68. PubMed ID: 17019404
[TBL] [Abstract][Full Text] [Related]
13. The localization of brain sites of anxiogenic-like effects of urocortin-2.
Skórzewska A; Bidziński A; Lehner M; Turzyńska D; Sobolewska A; Wisłowska-Stanek A; Maciejak P; Szyndler J; Płaźnik A
Neuropeptides; 2011 Feb; 45(1):83-92. PubMed ID: 21168912
[TBL] [Abstract][Full Text] [Related]
14. Infusion of galanin into the mid-caudal portion of the dorsal raphe nucleus has an anxiolytic effect on rats in the elevated T-maze.
Silote GP; Rosal AB; de Souza MM; Beijamini V
Behav Brain Res; 2013 Sep; 252():312-7. PubMed ID: 23791934
[TBL] [Abstract][Full Text] [Related]
15. A combinatorial modulation of synaptic plasticity in the rat medial amygdala by oxytocin, urocortin3 and estrogen.
Frankiensztajn LM; Gur-Pollack R; Wagner S
Psychoneuroendocrinology; 2018 Jun; 92():95-102. PubMed ID: 29674171
[TBL] [Abstract][Full Text] [Related]
16. Urocortin prevents indomethacin-induced small intestinal lesions in rats through activation of CRF2 receptors.
Kubo Y; Kumano A; Kamei K; Amagase K; Abe N; Takeuchi K
Dig Dis Sci; 2010 Jun; 55(6):1570-80. PubMed ID: 19707872
[TBL] [Abstract][Full Text] [Related]
17. Locomotor suppressive and anxiolytic-like effects of urocortin 3, a highly selective type 2 corticotropin-releasing factor agonist.
Valdez GR; Zorrilla EP; Rivier J; Vale WW; Koob GF
Brain Res; 2003 Aug; 980(2):206-12. PubMed ID: 12867260
[TBL] [Abstract][Full Text] [Related]
18. Activation of 5-HT1A receptors in the rat basolateral amygdala induces both anxiolytic and antipanic-like effects.
Strauss CV; Vicente MA; Zangrossi H
Behav Brain Res; 2013 Jun; 246():103-10. PubMed ID: 23499701
[TBL] [Abstract][Full Text] [Related]
19. Brain penetrance, receptor occupancy and antistress in vivo efficacy of a small molecule corticotropin releasing factor type I receptor selective antagonist.
Heinrichs SC; De Souza EB; Schulteis G; Lapsansky JL; Grigoriadis DE
Neuropsychopharmacology; 2002 Aug; 27(2):194-202. PubMed ID: 12093593
[TBL] [Abstract][Full Text] [Related]
20. Effects of acute restraint and unpredictable chronic mild stress on brain corticotrophin releasing factor mRNA in the elevated T-maze.
de Andrade JS; Céspedes IC; Abrão RO; da Silva JM; Ceneviva R; Ribeiro DA; Bittencourt JC; Viana MB
Behav Brain Res; 2018 Jan; 337():139-150. PubMed ID: 28935440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
